Julphar (Gulf Pharmaceutical Industries) Essay Example | Topics and Well Written Essays - 1750 words

Julphar (Gulf Pharmaceutical Industries) - Essay physical exertionRwanda requires companies to observe patent laws. Explicit registration procedures are in order to protect the work of innovators. Since Julphar get out be in exporting materials needed for the production of medicine in Rwanda, it will be portion for a company to consider patent issues associated with exports to Rwanda. Incentives offered by the government of Rwanda to patients provide the company an opportunity to line up the costs of producing new medicine (GTZ, 2006).The political environment in Rwanda is stable after the country emerged from the 1994 skirmishes. political turmoil affects operations of a business because wars may erupt (GTZ, 2006). The government of Rwanda is stable with the country arrangement progress in exercising governance. Julphar will have an advantage because the Rwandan government supports external investors who enjoy legion(predicate) business incentives. When the regime in power is s table, opportunities are opened for investors unlike when the government is with dictators. Rwanda has continued to place down increased GDP in the past few long time. More citizens are, at that placefore, able to purchase goods and services. The growth implies that there will be a ready market for the companys product (GTZ, 2006).Economic conditions in Rwanda may create opportunities or threats to Julphar. The countrys GDP has continued to improve over the years implying that the existence of a robust, ready market because consumers have the purchasing power. The social, cultural practices and taboos will equally intermit the company to new opportunities or threats since they influence consumption patterns (GTZ, 2010).Pharmaceutical industry is among the fastest growing industries globally. The developing of the industry has been by via the efforts of the government to have a higher budget for carrying out marketing investigate and developmental projects in the pharmaceutical industry. The industry is worth more than $734, and it is expected to grow further (UK